July 30, 2015
Recommended Topic Related To:

Surfaxin

"The U.S. Food and Drug Administration today approved Anoro Ellipta (umeclidinium and vilanterol inhalation powder) for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ("...

Surfaxin




Overdosage
Contraindications

OVERDOSE

There have been no reports of overdose following the administration of SURFAXIN.

If respiration, ventilation, or oxygenation is clearly affected after an accidental overdose, aspirate as much of the suspension as possible and provide the infant with supportive treatment.

CONTRAINDICATIONS

None.

Last reviewed on RxList: 3/16/2012
This monograph has been modified to include the generic and brand name in many instances.

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.